Neogenomics Inc (NEO) Institutional Ownership

Ownership Summary

Neogenomics Inc (NASDAQ:NEO) currently has 247 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• These investors collectively held 100.0% of the company's total shares outstanding in September 2025, up from 98.6% in June 2025.
• The company experienced a 2.14% quarterly change in institutional shares held, alongside a decrease of 7.49% in total owners annually.
• During the quarter, 108 institutions bought more Neogenomics shares, 93 sold shares, and 46 of the 247 total investors held their position steady.
• Collectively, institutional investors increased their stake in Neogenomics to 129.13Mn shares as of September 2025, a change that is up by 2.70Mn shares quarter on quarter and up 5.16Mn shares year over year.
• BlackRock, Inc.'s holding of 19.30Mn shares as of September 30, 2025 makes it the primary institutional investor in Neogenomics, owning 14.94% of the stock.
• Among the most significant buyers of Neogenomics during September 2025 were First Light Asset Management, LLC (3.08Mn), MILLENNIUM MANAGEMENT LLC (2.66Mn), CITADEL ADVISORS LLC (2.57Mn), D. E. Shaw & Co., Inc. (2.36Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (2.30Mn).
• Leading sellers of Neogenomics stock in September 2025 included BROWN ADVISORY INC (3.86Mn), AMERICAN CENTURY COMPANIES INC (3.50Mn), MACQUARIE GROUP LTD (2.27Mn), T. Rowe Price Investment Management, Inc. (1.96Mn), JANUS HENDERSON GROUP PLC (1.94Mn).
• The top 10 institutional holders of Neogenomics for the quarter ending September 2025 included BlackRock, Inc. (19.30Mn), VANGUARD GROUP INC (13.90Mn), First Light Asset Management, LLC (9.93Mn), Greenhouse Funds LLLP (8.22Mn), MILLENNIUM MANAGEMENT LLC (6.22Mn), STATE STREET CORP (5.02Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (4.45Mn), DIMENSIONAL FUND ADVISORS LP (3.83Mn), SCHRODER INVESTMENT MANAGEMENT GROUP (3.48Mn), D. E. Shaw & Co., Inc. (3.30Mn).